C12orf54 Inhibitors
Chemical inhibitors of protein C12orf54 can modulate the activity of this protein through a variety of mechanisms by targeting different signaling pathways and enzymes involved in cellular processes. Staurosporine serves as a broad-spectrum protein kinase inhibitor, which can inhibit the phosphorylation necessary for the function of C12orf54. By preventing kinase activity, staurosporine can halt the activation of C12orf54 that is contingent on phosphorylation events. Similarly, Rapamycin, by inhibiting mTOR, can suppress the downstream effects of pathways that may be crucial for C12orf54 function, leading to reduced protein synthesis and alterations in the cell cycle that would otherwise be necessary for the full activity of C12orf54.
LY294002 and Wortmannin both target PI3K, disrupting the AKT/mTOR signaling pathway, which is central to cell survival and proliferation. This disruption can impede the activation of C12orf54 if it is a downstream effector in this pathway. PD98059 and U0126, as MEK inhibitors, and Sorafenib, as a RAF kinase inhibitor, prevent the activation of the MAPK/ERK pathway, which is responsible for regulating cellular growth and differentiation. This inhibition can prevent the necessary signaling required for C12orf54 activity. SB203580's selective inhibition of p38 MAPK can similarly interrupt stress response signaling pathways that may regulate C12orf54. PP2 and Dasatinib, which inhibit Src family tyrosine kinases and Bcr-Abl kinases respectively, block signaling pathways that are vital for the regulation of various cellular processes, thereby potentially hindering the functional activity of C12orf54. Sunitinib's interference with receptor tyrosine kinases can lead to the inhibition of pathways that C12orf54 may rely on for its activation. Lastly, SP600125, by inhibiting JNK, can obstruct the signaling that C12orf54 would require if it is regulated by the stress-activated MAPK pathway, further demonstrating the diverse array of mechanisms by which chemical inhibitors can modulate the activity of C12orf54.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent, non-selective inhibitor of protein kinases. Given that protein kinases are responsible for phosphorylation, which in turn regulates the activity of many proteins, including C12orf54, staurosporine can inhibit the phosphorylation process required for C12orf54's function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin specifically inhibits mTOR, a central molecule in cellular growth and metabolism. Inhibition of mTOR can lead to a decrease in protein synthesis and cell cycle arrest, thus functionally inhibiting proteins downstream or within the same pathway as C12orf54. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K. PI3K is involved in the AKT/mTOR signaling pathway, which is crucial for cell survival and proliferation. By inhibiting PI3K, LY294002 can suppress the AKT/mTOR pathway, potentially inhibiting C12orf54 if it functions downstream of this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is a part of the MAPK/ERK pathway, a pathway that can regulate various cellular functions including growth and differentiation. By inhibiting MEK, PD98059 can prevent the activation of the ERK pathway, which may be required for C12orf54's activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor that functions similarly to PD98059 by inhibiting the MAPK/ERK pathway. Blocking this pathway can prevent the functional activity of proteins that are regulated by this pathway, including C12orf54. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAPK, which is involved in response to stress stimuli and cytokines. The inhibition of p38 MAPK can prevent the downstream signaling required for the activity of proteins like C12orf54, which may rely on this pathway for its function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K, similar to LY294002, and by inhibiting PI3K, it can disrupt the AKT/mTOR signaling pathway, potentially inhibiting the functional activity of C12orf54 if it operates within this pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. Src kinases are involved in various signaling pathways that regulate cellular proliferation, survival, and differentiation. Inhibition of these kinases by PP2 can hinder pathways that C12orf54 may utilize for its function. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a Bcr-Abl and Src family kinase inhibitor. By inhibiting these kinases, Dasatinib can disrupt signaling pathways that are essential for the activity of proteins such as C12orf54, assuming C12orf54's activity is influenced by these pathways. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a multikinase inhibitor that targets RAF kinases, among others. RAF is part of the MAPK/ERK signaling pathway, and its inhibition by Sorafenib can lead to a reduction in the signaling necessary for the function of proteins like C12orf54. | ||||||